BS

Barmavath Sai Teja

Active Director Director DIN 11385571
DIN 11385571 First appointment Nov 2025 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Barmavath Sai Teja

Data last updated:

Barmavath Sai Teja is a Director at Tamsa Pharmaceuticals Private Limited (since 2025). The company operates in Pharma.

DIN 11385571
Primary Designation Director
Industry Pharma
First Appointment 17 Nov 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director17 Nov 20252025Active

Directorship timeline

Open interactive timeline →
Tamsa Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Barmavath Sai Teja

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Barmavath Sai Teja

Barmavath Sai Teja currently holds 1 directorship: Tamsa Pharmaceuticals Private Limited (Director, since 17 Nov 2025).

Barmavath Sai Teja was first appointed on 17 Nov 2025 as Director at Tamsa Pharmaceuticals Private Limited.

The current boards of Barmavath Sai Teja's companies include Barigela Nishnath (Tamsa Pharmaceuticals Private Limited), Bhaskar Bandari (Tamsa Pharmaceuticals Private Limited), Prahlad Tularam Sati (Tamsa Pharmaceuticals Private Limited), Thirupathi Reddy Pochampally (Tamsa Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available